Huaizhong Health Group, Inc.
ADAD · OTC
1/31/2023 | 10/31/2022 | 7/31/2022 | 4/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 5.23 | -0.81 | 0.00 | 104.55 |
| FCF Yield | -0.03% | -0.10% | 0.00% | 0.00% |
| EV / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 |
| Quality | ||||
| ROIC | 55.24% | -198.54% | 160.81% | 84.83% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.00 | 4.16 | -0.00 | -0.00 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 65.49% | -513,898.32% | -3.25% | 100.06% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |